Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers

PURPOSE: Intravitreal injection of antiangiogenic agents is becoming a standard treatment for neovascular retinal diseases. Sustained release of therapeutics by injecting colloidal carriers is a promising approach to reduce the injection frequency, which reduces treatment burdens and the risk of com...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hao, Liu, Wenzhong, Sorenson, Christine M., Sheibani, Nader, Albert, Daniel M., Senanayake, Thulani, Vinogradov, Serguei, Henkin, Jack, Zhang, Hao F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2017
Materias:
Physiology and Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634351/
https://www.ncbi.nlm.nih.gov/pubmed/28986592
http://dx.doi.org/10.1167/iovs.17-22160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634351/
https://www.ncbi.nlm.nih.gov/pubmed/28986592
http://dx.doi.org/10.1167/iovs.17-22160

Ejemplares similares